Abstract
We report a high incidence of neutropenia in patients treated with rituximab prior to and following autologous stem cell transplantation (ASCT). Fourteen patients with follicular or mantle-cell lymphoma were treated with high dose (HD) therapy followed by an in vivo-purged autologous graft.
MeSH terms
-
Adult
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Bone Marrow Purging / adverse effects
-
Female
-
Humans
-
Lymphoma, Follicular / therapy
-
Lymphoma, Mantle-Cell / therapy
-
Male
-
Middle Aged
-
Neutropenia / etiology*
-
Peripheral Blood Stem Cell Transplantation / adverse effects*
-
Rituximab
-
Transplantation, Autologous
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab